Back

Effect of recombinant erythropoietin after moderate-to-severe #TBI in #ICU
EPO vs placebo did not improve overall long-term outcomes or QoL, but limited sample size makes difficult to make final conclusions.
#FOAMcc @ICM
https://rdcu.be/dgjia

Below visual abstract